Glucose Biosensors Market Analysis and Forecast (2023-2032) 

Glucose Biosensors Market Size - By Type (Continuous Glucose Monitoring, Self-monitoring Blood Glucose), By Technology (Electrochemical Biosensors, Optical Biosensors), By End-Use (Hospitals, Home Care, Diagnostic Centers & Clinics), Global Forecast, 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.2.1&nbsp;&nbsp;&nbsp; Data collection

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1.1&nbsp;&nbsp;&nbsp; Glucose biosensors industry 360&deg; synopsis, 2018 - 2032 (USD Million)

2.2&nbsp;&nbsp;&nbsp; Business trends

2.3&nbsp;&nbsp;&nbsp; Regional trends (USD Million &amp; Units)

2.4&nbsp;&nbsp;&nbsp; Type trends (USD Million &amp; Units)

2.5&nbsp;&nbsp;&nbsp; Technology trends

2.6&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Glucose Biosensors Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing number of patients suffering from diabetes across the world

3.2.1.2&nbsp;&nbsp;&nbsp;Rising demand for self-monitoring devices globally

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing government initiatives to generate awareness regarding diabetes

3.2.1.4&nbsp;&nbsp;&nbsp;Technological advancements in glucose biosensor devices

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High cost of glucose biosensors devices

3.2.2.2&nbsp;&nbsp;&nbsp;Stringent regulatory scenario

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By type

3.3.2&nbsp;&nbsp;&nbsp; By technology

3.3.3&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; U.S.

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive dashboard, 2022

4.4&nbsp;&nbsp;&nbsp; Company market share analysis, 2022

4.5&nbsp;&nbsp;&nbsp; Vendor matrix analysis, 2022

4.6&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.7&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.8&nbsp;&nbsp;&nbsp; Strategic outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Glucose Biosensors Market Size and Forecast, By Type (USD Million &amp; Units)

5.1&nbsp;&nbsp;&nbsp; Key trends, by type

5.2&nbsp;&nbsp;&nbsp; Continuous Glucose Monitoring (CGM)

5.3&nbsp;&nbsp;&nbsp; Self-monitoring Blood Glucose (SMBG)

Chapter 6&nbsp;&nbsp;&nbsp;Glucose Biosensors Market Size and Forecast, By Technology (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by technology

6.2&nbsp;&nbsp;&nbsp; Electrochemical biosensors

6.3&nbsp;&nbsp;&nbsp; Optical biosensors

Chapter 7&nbsp;&nbsp;&nbsp;Glucose Biosensors Market Size and Forecast, By End-use (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Home healthcare

7.4&nbsp;&nbsp;&nbsp; Diagnostic centres &amp; clinics

7.5&nbsp;&nbsp;&nbsp; Others

Chapter 8&nbsp;&nbsp;&nbsp;Glucose Biosensors Market Size and Forecast, By Region (USD Million &amp; Units)

8.1&nbsp;&nbsp;&nbsp; Key trends, by region

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; The Netherlands

8.3.7&nbsp;&nbsp;&nbsp; Switzerland

8.3.8&nbsp;&nbsp;&nbsp; Poland

8.3.9&nbsp;&nbsp;&nbsp; Denmark

8.3.10&nbsp;&nbsp;&nbsp; Sweden

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; New Zealand

8.4.7&nbsp;&nbsp;&nbsp; Thailand

8.4.8&nbsp;&nbsp;&nbsp; Indonesia

8.4.9&nbsp;&nbsp;&nbsp; Vietnam

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Colombia

8.5.5&nbsp;&nbsp;&nbsp; Chile

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Turkey

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Ascensia Diabetes Care Holdings AG. (Senseonics, Inc.)

9.2&nbsp;&nbsp;&nbsp; Lifescan, Inc.

9.3&nbsp;&nbsp;&nbsp; Universal Biosensors

9.4&nbsp;&nbsp;&nbsp; Nova Biomedical

9.5&nbsp;&nbsp;&nbsp; Med Trust

9.6&nbsp;&nbsp;&nbsp; Taidoc Technology Corporation

9.7&nbsp;&nbsp;&nbsp; Roche AG.

9.8&nbsp;&nbsp;&nbsp; Dexcom

9.9&nbsp;&nbsp;&nbsp; i-SENS, Inc.

9.10&nbsp;&nbsp;&nbsp; Abbott Laboratories

9.11&nbsp;&nbsp;&nbsp; Trividia Health

9.12&nbsp;&nbsp;&nbsp; Pinnacle Technology

9.13&nbsp;&nbsp;&nbsp; Medtronic plc 
&nbsp;

Glucose Biosensors Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters